PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Developing a Public Health Response to Mycoplasma genitalium.

Abstract Although Mycoplasma genitalium is increasingly recognized as a sexually transmitted pathogen, at present there is no defined public health response to this relatively newly identified sexually transmitted infection. Currently available data are insufficient to justify routinely screening any defined population for M. genitalium infection. More effective therapies, data on acceptability of screening and its impact on clinical outcomes, and better information on the natural history of infection will likely be required before the value of potential screening programs can be adequately assessed. Insofar as diagnostic tests are available or become available in the near future, clinicians and public health agencies should consider integrating M. genitalium testing into the management of persons with sexually transmitted infection (STI) syndromes associated with the infection (ie urethritis, cervicitis, and pelvic inflammatory disease) and their sex partners. Antimicrobial-resistant M. genitalium is a significant problem and may require clinicians and public health authorities to reconsider the management of STI syndromes in an effort to prevent the emergence of ever more resistant M. genitalium infections.
PMID
Related Publications

Mycoplasma genitalium Infection in Men.

Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g!

Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women.

Mycoplasma genitalium, an emerging sexually transmitted pathogen.

Mycoplasma genitalium: An emergent sexually transmitted disease?

Authors

Mayor MeshTerms

Public Health

Keywords

Mycoplasma genitalium

prevention

public health

Journal Title the journal of infectious diseases
Publication Year Start




PMID- 28838079
OWN - NLM
STAT- MEDLINE
DA  - 20170825
DCOM- 20170905
LR  - 20170906
IS  - 1537-6613 (Electronic)
IS  - 0022-1899 (Linking)
VI  - 216
IP  - suppl_2
DP  - 2017 Jul 15
TI  - Developing a Public Health Response to Mycoplasma genitalium.
PG  - S420-S426
LID - 10.1093/infdis/jix200 [doi]
AB  - Although Mycoplasma genitalium is increasingly recognized as a sexually
      transmitted pathogen, at present there is no defined public health response to
      this relatively newly identified sexually transmitted infection. Currently
      available data are insufficient to justify routinely screening any defined
      population for M. genitalium infection. More effective therapies, data on
      acceptability of screening and its impact on clinical outcomes, and better
      information on the natural history of infection will likely be required before
      the value of potential screening programs can be adequately assessed. Insofar as 
      diagnostic tests are available or become available in the near future, clinicians
      and public health agencies should consider integrating M. genitalium testing into
      the management of persons with sexually transmitted infection (STI) syndromes
      associated with the infection (ie urethritis, cervicitis, and pelvic inflammatory
      disease) and their sex partners. Antimicrobial-resistant M. genitalium is a
      significant problem and may require clinicians and public health authorities to
      reconsider the management of STI syndromes in an effort to prevent the emergence 
      of ever more resistant M. genitalium infections.
CI  - (c) The Author 2017. Published by Oxford University Press for the Infectious
      Diseases Society of America. All rights reserved. For permissions, e-mail:
      [email protected]
FAU - Golden, Matthew R
AU  - Golden MR
AD  - Center for AIDS and STD, University of Washington, Seattle.
AD  - Public Health - Seattle & King County, Washington.
FAU - Workowski, Kimberly A
AU  - Workowski KA
AD  - Department of Infectious Diseases, Emory School of Medicine.
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia.
FAU - Bolan, Gail
AU  - Bolan G
AD  - Centers for Disease Control and Prevention, Atlanta, Georgia.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - J Infect Dis
JT  - The Journal of infectious diseases
JID - 0413675
RN  - 0 (Anti-Bacterial Agents)
SB  - AIM
SB  - IM
MH  - Anti-Bacterial Agents/therapeutic use
MH  - Drug Resistance, Bacterial
MH  - Female
MH  - Humans
MH  - Male
MH  - Mycoplasma Infections/complications/drug therapy/*epidemiology
MH  - Mycoplasma genitalium/*isolation & purification
MH  - *Public Health
MH  - Sexual Partners
MH  - Sexually Transmitted Diseases, Bacterial/complications/*epidemiology/microbiology
OTO - NOTNLM
OT  - Mycoplasma genitalium
OT  - prevention
OT  - public health
EDAT- 2017/08/26 06:00
MHDA- 2017/09/07 06:00
CRDT- 2017/08/26 06:00
AID - 4040986 [pii]
AID - 10.1093/infdis/jix200 [doi]
PST - ppublish
SO  - J Infect Dis. 2017 Jul 15;216(suppl_2):S420-S426. doi: 10.1093/infdis/jix200.